Nurtec ODT, rimegepant
Named-patient access overview. Nurtec ODT is coordinated by Reserve Meds for international patients via physician-led cross-border sourcing.
This page is informational, not medical advice.
About Nurtec ODT
Nurtec ODT (rimegepant) is an oral calcitonin gene-related peptide (CGRP) receptor antagonist, originally developed by Biohaven and now part of the Pfizer portfolio. It is the first oral CGRP antagonist approved by the US FDA both for the acute treatment of migraine and for the preventive treatment of episodic migraine in adults. Nurtec ODT works by blocking CGRP, a neuropeptide centrally involved in the migraine pain pathway, at its receptor.
Nurtec ODT is supplied as a 75 mg orally disintegrating tablet that dissolves on the tongue without water. For acute treatment, it is taken as a single tablet at the onset of a migraine attack. For prevention of episodic migraine, it is taken every other day. Storage is at room temperature in the original blister, which simplifies international transit because no cold-chain layer is required.
For international patients whose home-country formulary either does not list Nurtec ODT or limits coverage to a small subset of patients, a US-sourced named-patient pathway is often the most practical route to consistent therapy, particularly for those on a preventive regimen who need supply continuity.
Who Nurtec ODT is for
Nurtec ODT is generally considered for adults with migraine who need a non-triptan option for acute treatment, those who do not tolerate or cannot use triptans for cardiovascular or other reasons, and those with episodic migraine who would benefit from a preventive regimen that does not require an injection. The treating neurologist or primary-care physician weighs migraine frequency, severity, prior therapy response, and other factors before initiating Nurtec ODT.
How Reserve Meds coordinates Nurtec ODT
- Patient or treating physician submits a named-patient request through Reserve Meds intake.
- Our clinical team verifies appropriateness of Nurtec ODT for the patient's migraine pattern and destination country.
- The treating physician issues a prescription and a brief clinical justification.
- Country-specific named-patient program or personal-import documentation is prepared.
- Nurtec ODT is sourced from a DSCSA-compliant US specialty wholesaler with full serial traceability.
- Shipment is coordinated to the patient's physician, hospital pharmacy, or approved address, with quantity sized to the prescribed acute and preventive use pattern.
Pricing and what shapes it
Nurtec ODT's landed price for international patients is shaped by the wholesale acquisition cost in the United States, destination-country import duties and value-added tax, logistics fees, and the Reserve Meds coordination fee. The cost scales with the prescribed number of tablets per cycle, which itself depends on whether the patient is using Nurtec ODT acutely, preventively, or both. Once intake is complete and destination confirmed, our coordinator issues a firm written quote covering the full landed cost before any wire is requested.
Timing expectations
From a complete intake, indicative timing for Nurtec ODT to reach a patient in our priority markets ranges from approximately two to five weeks. The dominant variables are destination-country regulatory processing, completeness of the physician package, and customs clearance. Because Nurtec ODT is an orally disintegrating tablet at ambient temperature, transit risk is lower than for refrigerated biologics. Reserve Meds assigns each case a single named coordinator who maintains continuity from intake through delivery and refill.
Access by country
Reserve Meds publishes a detailed country deep-dive for Nurtec ODT in every market we coordinate. Each page below covers the destination-country regulatory pathway, real costs in local currency and USD, indicative timelines, physician-credential requirements, and cold-chain handling. Tap any country to read the full deep-dive.
Storage and handling, in plain language
Nurtec ODT tablets are stable at room temperature in the original blister packaging. They should be kept dry, away from direct sunlight, and out of reach of children. There is no cold-chain requirement, which simplifies international transit. Reserve Meds packages each shipment with tamper-evident seals and documentation that matches the wholesaler's serial records, so the receiving physician can verify provenance on arrival.
Documentation the physician will be asked to provide
The typical package includes a current prescription, a brief clinical justification letter describing the patient's migraine history and prior management, a copy of the physician's license, and the destination-country named-patient or personal-import form where applicable. Reserve Meds prepares the country-specific paperwork; the physician supplies the clinical pieces. We aim to keep the physician's workload to under thirty minutes per case.
Privacy and data handling
Patient information collected through Reserve Meds intake is handled under HIPAA standards in the United States and the privacy regimes that apply in the destination country, including UAE PDPL, KSA PDPL, India DPDPA, and the EU GDPR where relevant. We share only the minimum necessary information with the prescribing physician, the wholesaler, the carrier, and any regulator who requires submission.
Start a request for Nurtec ODT
Submit a 60-second intake. Our clinical team will reach out as our first cohort opens with case-specific feasibility, timeline, and a formal quote.
Reserved for you.